USD10
CGEN acciones
Acerca de CompugenCompugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
USD10
CGEN acciones
Acerca de CompugenCompugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
No hay suficientes datos
CAPITALIZACIÓN DE MERCADO
197,62 M US$
PRECIO DE APERTURA
2,11 US$
BAJO (1Y)
1,13 US$
ALTO (1Y)
2,38 US$
BAJO (24H)
2,08 US$
Alza (24H)
2,17 US$
Volumen (24 h)
194,22 mil US$
5,2 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 2,11 US$ | |
1 día | 2,09 US$ | 0,00 % |
1 semana | 2,24 US$ | |
1 mes | 1,67 US$ | |
1 año | 1,62 US$ |
Una nueva era de Coinbase ha comenzado
El futuro del dinero está aquí. Sé uno de los primeros en obtener acceso y probar nuevas funciones en cuanto estén disponibles.
Crea una cuenta ahora